2023
Jensen I , Srivastava K, Minshall M, Kemp R. Estimating the lifetime burden of illness in patients with bronchiolitis obliterans syndrome. Abstract EE539 , ISPOR 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Bean K, Miller B, Jensen I , Fields C, Pang F. Evaluating the face validity of health state utility values (HSUVS) for metachromatic leukodystrophy (MLD). Abstract EE285 , ISPOR 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Bean K, Olaye A, Miller B, Jensen I , Dean R, Pang F. Direct cost analysis associated with the management of patients with metachromatic leukodystrophy (MLD) across nine European countries. Abstract EE408 , ISPOR 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Broome CM, Mitchell M , Bylsma L , Shara N, Fernandez S, Catlett J, Lai J, Dong K, et al. Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH). Abstract P1202. Poster presented to European Hematology Association-EHA2023, Frankfurt, June 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Epidemiology
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen CD, Eichler F. Healthcare utilization, burden of illness, and mortality in adults with adrenomyeloneuropathy: The case for genetic therapies. Poster presentation, American Society of Cell and Gene Therapy Meeting, Los Angeles, CA, May 2023.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen CD, Eichler F. Substantial burden of illness and mortality in men with adrenomyeloneuropathy. Poster presentation at American Academy of Neurology Annual Meeting, April 2023.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Minshall M, Emden M, McLin R, Kemp P, Pontenani F, Cardosi L, Sacks N . The cost of non-cystic fibrosis bronchiectasis (NCFB) in patients with commercial insurance or Medicare coverage in the US. Poster presentation, ISPOR, April 2023.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Eichler F, Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen C. The economic impact of adrenomyeloneuropathy (AMN) on direct medical costs in commercially insured US adults: A retrospective study. Poster presentation, ISPOR 27th International Meeting, Boston, MA, April 2023.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen C. Hospitalizations, clinical characteristics and mortality in adults with adrenomyeloneuropathy (AMN): A retrospective study. Poster presentation, ISPOR 27th International Meeting, Boston, MA, April 2023.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Wood CT, Walter E, Espinosa CM, Enriquez-Bruce ME, Budhecha S, Elliott A, Domachowske J,…, Suh M , et al. Seasonality of infant lower respiratory tract infections, including those caused by RSV, was altered during the COVID-19 pandemic: Results from four US health systems. Poster #642 at the Pediatric Academic Societies Meeting, Washington, DC, April 2023.
A Division of